
FSI Nutrition, the developer and manufacturer of the 8-Ball Nutrition brand, has been intricately involved in the bioengineering of new ingredient forms and delivery systems for over a decade. This focused commitment to research has resulted in two United States patents that demonstrate FSI’s creativity in molecular and cellular architecture.
Why such an unparalleled focus on science-based ingredients and delivery methods? It is the combination of ethical scientific practices and the unquestioned lack of industry discipline.
Due to the absence of effective policy and structure within the dietary supplement industry, any athlete is in danger of testing positive to a plethora of illegal and banned substances. This is caused by the inability of the industry, for unknown reasons, to reprimand marketing companies and manufacturers for deliberately mislabeling and misrepresenting the ingredients in the products they produce and sell.
Due to this fact, FSI turns to the U.S. Patent and Trademark Office to protect any new formulas and delivery systems it invents, forcing all companies wishing to utilize those ingredients to deal directly with FSI. As a result, FSI is able to control the formulation, production and distribution of any products within the scope of its patents. This results in safer, more effective ingredients that ultimately benefit and protect the athlete who uses them.
(PDF) U.S. Patent #5,925,378 - Creatine Delivery
(PDF) U.S. Patent #6,294,579 - Tyrosine Delivery










